Skip to main content
SpringerLink
Log in

Vasopressin and Human Behavior

  • Chapter
Book cover Vasopressin

Abstract

Peptides related to the pituitary hormone vasopressin (VP) have been found to influence aspects of memory processes and learning in laboratory animals (De Wied, 1969; see De Wied, 1983, for review). This finding has led to the suggestion that VP might have a clinical application in the treatment of human memory disorders. Unfortunately, it is not simple to state whether VP has been found effective. This is because clinical studies differ with respect to the nature of the patient population (e.g., brain trauma, alcoholism, depression) and the methods of testing used. In addition, there is wide variation in pharmacological parameters, such as the dose, route, and frequency of peptide administration. Accordingly, some studies report positive effects of VP administration, whereas others are negative (Jolles, 1983b).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson, L. T., David, R., Bonnet, R., and Dancis, J., 1979, Passive avoidance learning in Lesch-Nyhan disease: Effect of l-desamino-8-arginine-vasopressin, Life Sci. 24: 905–910.

    PubMed  CAS  Google Scholar 

  • Ang, V. T. Y., and Jenkins, J. S., 1982, Blood CSF barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog, J. Endocrinol. 93: 319–325.

    PubMed  CAS  Google Scholar 

  • Beckwith, B. E., Petros, T., Kanaan-Beckwith, S., Couk, D. I., and Haug, R. J., 1982, Vasopressin analog (DDAVP) facilitates concept learning in human males, Peptides 3: 627–630.

    PubMed  CAS  Google Scholar 

  • Beckwith, B. E., Couk, D. I., and Till, T. S., 1983, Vaspressin analog influences the performance of males on a reaction time task, Peptides 4: 707–709.

    PubMed  CAS  Google Scholar 

  • Beckwith, B. E., Till, R. E., and Schneider, V., 1984, Vasopressin analog (DDAVP) improves memory in human males, Peptides 5: 819–822.

    PubMed  CAS  Google Scholar 

  • Blake, D. R., Dodd, M. J., and Grimley Evans, J., 1978, Vasopressin in amnesia, Lancet 1: 608.

    PubMed  CAS  Google Scholar 

  • Branconnier, R. J., 1983, Computerized psychometrics, in: Assessment in Geriatric Psychopharmacology (T. Crook, S. Ferris, and R. Bartus, eds.), pp. 203–213, Mark Powley Association, New Canaan, Connecticut.

    Google Scholar 

  • Brand, N., and Jolies, J., 1985, Learning and retrieval rate of words presented auditorially and visually, J. Gen. Psychol 112: 210–210.

    Google Scholar 

  • Brand, N., and Jolies, J., 1987, Information processing in depression and anxiety, Psychol. Med. 17: 145–154.

    PubMed  CAS  Google Scholar 

  • Buijs, R. M., 1978, Intra-and extrahypothalamic vasopressin and oxytocin pathways in the rat: Pathways to the limbic system, medulla oblongata and spinal cord, Cell Tissue Res. 192: 423–435.

    PubMed  CAS  Google Scholar 

  • Butters, N., 1985, Alcoholic Korsakoff s syndrome: Some unresolved issues, concerning etiology, neuropathology and cognitive defects. J. Exp. Clin. Neuropsychol. 7: 101–210.

    Google Scholar 

  • Calandra, C., Drago, F., and Filetti, S., 1980, Su un caso con turbe mnestische trattato con vasopressina, Min. Psychiat. 21: 63–66.

    CAS  Google Scholar 

  • Christensen, A. L., 1975, Luria’s Neuropsychological Investigation, Munksgaard, Copenhagen.

    Google Scholar 

  • Couk, D. I., and Beckwith, B. E., 1982, Effects of desmopressin acetate (DDAVP) on the learning of a brightness discrimination, Peptides 3: 521–526.

    PubMed  CAS  Google Scholar 

  • Delwaide, P. J., Devoitille, J. M., and Ylieff, M., 1980, Acute effects of drugs upon memory of patients with senile dementia, Acta Psychiatrica Belg. 80: 748–754.

    CAS  Google Scholar 

  • De Wied, D., 1969, Effects of peptide hormones on behavior, in: Frontiers in Neuroendocrinology (W. F. Ganong and L. Martini, eds.), pp. 97–140, Oxford University Press, London.

    Google Scholar 

  • De Wied, D., 1971, Longterm effect of vasopressin on the maintenance of a conditioned avoidance response in rats, Nature (Lond.) 232: 58–60.

    Google Scholar 

  • De Wied, D., 1976, Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments, Life Sci. 19: 685–690.

    PubMed  Google Scholar 

  • De Wied, D., 1983, Central actions of neurohypophysial hormones, Prog. Brain Res. 60: 155–169.

    PubMed  Google Scholar 

  • De Wied, D., 1984, The importance of vasopressin in memory, Trends Neurosci 7: 62–63.

    Google Scholar 

  • De Wied, D., and Jolies, J., 1983, Neuropeptides derived from pro-opiomelanocortin: Behavioral, physiological and neurochemical effects, Physiol. Rev. 62: 976–1059.

    Google Scholar 

  • De Wied, D., Gaffon, O., Van Ree, J. M., and De Jong, W., 1984, Nature (Lond.) 308: 276–278.

    Google Scholar 

  • Dimond, S., 1980, Neuropsychology, Butterworths, London.

    Google Scholar 

  • Drago, F., Rapisarda, V., Calandra, A., Filetti, S., and Scapagnini, U., 1981, A clinical evaluation of vasopressin effects on memory disorders, Acta Ther. 7: 345–352.

    Google Scholar 

  • Durso, R., Fedio, P., Brouwers, P., Cox, C., Martin, A. J., Ruggieri, S. A., Tamminga, C. A., and Chase, T. N., 1982, Lysine vasopressin in Alzheimer’s disease. Neurology (NY.) 32: 674–677.

    CAS  Google Scholar 

  • Eisenberg, J., Chazon-Gologorsky, S., Hattab, J., and Belmaker, R.M., 1984, A controlled trial of vasopressin treatment in childhood learning disorder, Biol Psychiatry 19: 1137–1141.

    PubMed  CAS  Google Scholar 

  • Eisenberg, J., Hamburger-Bar, A., and Belmaker, R. H., 1984, The effect of vasopressin treatment on learning in Down’s syndrome, J. Neural Transm. 60: 143–147.

    PubMed  CAS  Google Scholar 

  • Fehm-Wolfsdorf, G., Born, J., Voigt, K-H., and Fehm, H-L., 1984, Human memory and neurohypophyseal hormones: Opposite effects of vasopressin and oxytocin, Psychoneuroendocrinology 9: 285–292.

    PubMed  CAS  Google Scholar 

  • Fehm-Wolfsdorf, G., Born, J., Elbert, Th., Voigt, K-H., and Fehm, L. H., 1985, Vasopressin does not enhance memory processes: A study in human twins, Peptides 6: 297–300.

    PubMed  CAS  Google Scholar 

  • Ferris, S. H., 1983, Neuropeptides in the treatment of Alzheimer’s disease, in: Alzheimer’s disease (B. Reisberg, ed.), pp. 369–373, Free Press/Macmillan, New York.

    Google Scholar 

  • Fewtrell, W. D., House, A. O., Jamie, P. F., Oates, M. R., and Cooper, J. E., 1982, Effects of vasopressin on memory and new learning in a brain-injured population, Psychol. Med. 12: 423–425.

    PubMed  CAS  Google Scholar 

  • Forisz, L., 1952a, Treatment of mental patients with antidiuretic hormone of the posterior pituitary, Dis. Nerv. Syst. 13: 42–44.

    Google Scholar 

  • Forisz, L., 1952b, The use of Pitressin in the treatment of schizophrenia with deterioration, N. C. Med. J. 13: 76–80.

    Google Scholar 

  • Fraenkel, H. M., van Beek-Verbeek, G., Fabriek, A. J., and van Ree, J. M., 1983, Desglycinamide9-Arginine8-Vasopressin and ambulant methadone-detoxificaiton of heroin addicts, Alcohol Alcoholism 18: 331–335.

    Google Scholar 

  • Franceschi, M., Tancredi, O., Savio, G., and Smirne, S., 1982, Vasopressin and physostigmine in the treatment of amnesia, Eur. Neurol. 21: 388–391.

    PubMed  CAS  Google Scholar 

  • Frolkis, V. V., Golovchenko, S. F., Medved, V. I., and Frolkis, R. A., 1982, Vasopressin and cardiovascular system in aging, Gerontology 28: 290–302.

    PubMed  CAS  Google Scholar 

  • Gash, D. M., and Thomas, G. T., 1983, What is the importance of vasopressin in memory processes?, Trends Neurosci. 6: 197–198.

    CAS  Google Scholar 

  • Gash, D. M., and Thomas, G. T., 1984, The importance of vasopressin in memory:Reply, Trends Neurosci. 7: 64–65.

    CAS  Google Scholar 

  • Gilot, P., Crabbe, J., and Legros, J. J., 1980, Bilan mnésique de cinq sujects présentant un diabète central idiopathique familiar, Acta Psychiatrica Belg. 80: 755–761.

    CAS  Google Scholar 

  • Gold, P. E., and Van Buskirk, A., 1976, Effects of posttrial hormone injections on memory processes, Horm.Behav. 7: 509–517.

    PubMed  CAS  Google Scholar 

  • Gold, P. W., Ballenger, J. C., Weingartner, H., Goodwin, F. K., and Post, R. M., 1979, Effects of l-desamino-8-D-arginine vasopressin on behavior and cognition in primary affective disorders, Lancet. 1: 992–994.

    Google Scholar 

  • Gold, P. W., Robertson, G. L., Ballenger, J. C., Goodwin, F. K., Rubinow, D. R., Kellner, C., and Post, R. M., 1983, Neurohypophyseal function in affective illness, Psychopharmacol. Bull. 19: 426–431.

    PubMed  CAS  Google Scholar 

  • Jenkins, J. S., Mather, H. M., and Coughlan, A. K., 1982, Effects of desmopressin in normal and impaired memory, J. Neurol. Neurosurg. Psychiatry 45: 830–831.

    PubMed  CAS  Google Scholar 

  • Jenkins, J. S., Mather, H. M., Coughlan, A. K., and Jenkins, D. G., 1979, Desmopressin in posttraumatic amnesia, Lancet 1245–1246.

    Google Scholar 

  • Jenkins, J. S., Mather, H. M., Coughlan, A. K., and Jenkins, D. G., 1981, Desmopressin and desglycinamide vasopressin in posttraumatic amnesia, Lancet 1: 39.

    PubMed  CAS  Google Scholar 

  • Jennekens-Schinkel, A., Wintzen, A. R., and Lanser, J. B. K., 1985, A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man, Prog. Neuropsychopharmacol. and Biol Psychiatry 9: 273–284.

    CAS  Google Scholar 

  • Jensen, J. P. A., 1980, Vasopressin therapy in Parkinson’s disease, Acta Neurol. Scand. 62: 197–199.

    PubMed  CAS  Google Scholar 

  • Jolies, J., 1983a, The pharmacology of memory, Int. Med. 3: 2–5.

    Google Scholar 

  • Jolies, J., 1983b, Vasopressin-like peptides and the treatment of memory disorders in man, Prog. Brain Res. 60: 169–182.

    Google Scholar 

  • Jolies, J., 1985, Early diagnosis of dementia: Possible contributions from neuropsychology, in: Aging of the Brain (W. H. Gispen and J. Traber, eds.), pp. 84–100, Springer-Verlag, Berlin.

    Google Scholar 

  • Jolies, J., 1986a, Neuropeptides and cognitive disorders, in: Psychiatric Disorders: Neurotransmitters and Neuropeptides (J. M. van Ree and J. Matthÿse, eds.), pp. 177–192, Elsevier, Amsterdam.

    Google Scholar 

  • Jolies, J., 1986b, Cognitive, emotional, and behavioral dysfunctions in aging and dementia, Prog. Brain Res. 70: 15–39.

    Google Scholar 

  • Jolies, J., and Hijman, R., 1983, The neuropsychology of aging and dementia, Dev. Neurol. 7: 277–250.

    Google Scholar 

  • Jolies, J., and Gaillard, A.W.K., A paper and pencil version of the Sternberg memory comparison task (Submitted for publication).

    Google Scholar 

  • Kirkland, J., Lye, M., Goddard, C., Vargast, E., and Davies, I., 1984, Plasma arginine vasopressin in dehydrated elderly patients, Clin. Endocrinol. 20: 451–456.

    Google Scholar 

  • Koch-Henriksen, N., and Nielson, H., 1981, Vasopressin in post-traumatic amnesia, Lancet 1: 38–39.

    PubMed  CAS  Google Scholar 

  • Koizumi, H. M., Rowe, H., and Clark, R., 1981, Vasopressin (antidiuretic hormone) for postencephalitic memory loss: A pilot study, J. Clin. Psychiatry 42: 217.

    PubMed  CAS  Google Scholar 

  • Korsgaard, S., Casey, D. E., Damgaard Pedersen, N. E., Jørgensen, A., and Gerlach, J., 1981, Vasopressin in anergic schizophrenia, Psychopharmacology 74: 379–382.

    PubMed  CAS  Google Scholar 

  • Kovacs, G. L., Vecsei, L., Szabo, G., and Telegdy, G., 1977, The involvement of catecholaminergic mechanisms in the behavioral action of vasopressin, Neurosci, Lett. 5: 337–344.

    CAS  Google Scholar 

  • Kovacs, G. L., Bohus, B., and Versteeg, D. H. G., 1979, Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal noradrenergic bundle?, Brain Res. 172: 73–85.

    PubMed  CAS  Google Scholar 

  • Kovacs, G. L., Vecsei, L., Medve, L., and Telegdy, G., 1980, Effect of the endogenous vasopressin content of the brain on memory processes: The role of catecholaminergic mechanisms, Exp. Brain Res. 38: 357–361.

    PubMed  CAS  Google Scholar 

  • Kruse, H., Van Wimersma Greidanus, Tj. B., and De Wied, D., 1977, Barrel rotation induced by vasopressin and related peptides in rats, Pharmacol. Biochem. Behav. 7: 311–313.

    PubMed  CAS  Google Scholar 

  • Láczi, F., Valkusz, Zs., Laszlo, F. A., Wagner, A., Jardanhazy, T., Szasz, A., Szilard, J., and Telegdy, G., 1982, Effects of lysine-vasopressin and 1-desamino-8-D-arginine-vasopressin on the memory in healthy individuals and diabetes insipidus patients, Psychoneuroendocrinology 7: 185–193.

    PubMed  Google Scholar 

  • Láczi, R., Van Ree, J.M., Wagner, A., Valkusz, Zs., Jardanhazy, T., Kovacs, G. L., Telegdy, G., Szilard, J., Laszlo, F.A., and De Wied, D., 1983a, Effects of desglycinamide-arginine-vasopressin (DGAVP) on memory processes in diabetes insipidus patients and in non-diabetic subjects, Acta. Endocrinol. 102: 205–212.

    PubMed  Google Scholar 

  • Láczi, F., Van Ree, J. M., Balogh, L., Szasz, A., Jardanhazy, T., Wagner, A., Gaspar, L., Valkusz, Zs., Dobranovics, I., Szilard, J., Laszlo, F.A., and De Wied, D., 1983b, Lack of effect of DGAVP on memory in patients with Korsakoff syndrome, Acta. Endocrinol. 104: 177–182.

    PubMed  Google Scholar 

  • Legros, J. J., Gilot, P., Schmitz, S., Bruwier, M., Mantanus, H., and Timsit-Bertheir, M., 1980, Neurohypophyseal peptides and cognitive function: A clinical approach, in: Progress in Psychoneuroendocrinology (F. Brambilla, G. Racagni, D. De Wied, eds.), pp. 325–337, Elsevier, Amsterdam.

    Google Scholar 

  • Legros, J. J., and Lancranjan, I., 1984, Vasopressin in neuropsychiatric disorders, in: Psychoneuroendocrine Dysfunction (N. S. Shah and A. G. Donald, eds.), pp. 255–278, Plenum, New York.

    Google Scholar 

  • Legros, J. J., Gilot, P., Seron, X., Ciaessens, J., Adam, A., Moeglen, J.M., Audibert, A., and Berchier, P., 1978, Influence of vasopressin on learning and memory, Lancet 1: 41–42.

    PubMed  CAS  Google Scholar 

  • Lerer, B., Zabow, T., Egnal, N., and Belmaker, R.H., 1983, Biol. Psychiat. 18: 821–824.

    PubMed  CAS  Google Scholar 

  • Lezak, M. D., 1983, Neuropsychological Assessment, (2nd. ed.), Oxford University Press, New York.

    Google Scholar 

  • Lhermitte, F., and Signoret, J. L., 1972, Analyse neuropsychologique et diffèrentation des syndromes anmésiques, Rev. Neurol. 126: 161–178.

    PubMed  CAS  Google Scholar 

  • Lishman, V. A., 1980, Head injury, in: Organic Psychiatry, 2nd. ed., pp. 191–262, Oxford, Blackwell Scientific, London.

    Google Scholar 

  • Luersson, T. G., and Robertson, G.L., 1980, Cerebrospinal fluid vasopressin and vasotocin in health, in: Neurobiology of Cerebrospinal Fluid (J. H. Wood, ed.), pp. 613–625, Plenum, New York.

    Google Scholar 

  • Luria, A. R., 1976, The Neuropsychology of Memory, Winston, Washington, D. C.

    Google Scholar 

  • Luria, A. R., 1980, Higher Cortical Functions in Man, 2nd ed., Basic Books, New York.

    Google Scholar 

  • McGeer, P. L., Eccles, J. C., and McGeer, E. G., 1978, Neuronal mechanisms in learning and memory, in: Molecular Neurobiology of he Mammalian Brain, (P. L. McGeer, J. C. Eccles, and E. G. McGeer, eds.), pp. 501–535, Plenum, New York.

    Google Scholar 

  • Medvedev, V. I., Bakharev, V. D., Grechko, A. T., and Nezovibat’ko, V. N., 1981, Effect of vasopressin and adrenocorticotrophic hormone fragment ACTH4−7 on human memory, Hum. Physiol. 6: 307–310.

    Google Scholar 

  • Nebes, R. D., Reynolds, C. F. III, and Horn, L. C., 1984, The effect of vasopressin on memory in the healthy elderly, Psychiat. Res. 11: 49–59.

    CAS  Google Scholar 

  • Newcombe, F., 1980, Memory: A neuropsychological approach, Trends Neurosci. 3: 179–182.

    Google Scholar 

  • O’Keefe, J., and Nadel, L., 1978, The Hippocampus as a Cognitive Map, Clarendon Press, Oxford.

    Google Scholar 

  • Oliveros, J. C., Jandali, M. K., Timsit-Berthier, M., Remy, R., Benghezal, A., Audibert, A., and Moeglen, J. M., 1978, Vasopressin in amnesia, Lancet 1: 42.

    PubMed  CAS  Google Scholar 

  • Peabody, C. A., Thiemann, S., Pigache, R., Miller, T. P., Berger, Ph. A., Yesavage, J., and Tinklenberg, J. R., 1985, Desglycinamide-9-Arginine-8-Vasopressin(DGAVP, Organon 5667) in patients with dementia, Neurobiol. Aging 6: 95–100.

    PubMed  CAS  Google Scholar 

  • Perlow, M. J., Reppert, S. M., Artman, M. A., Fisher, P. A., Luf, S. M., and Robinson, A. G., 1982, Oxytocin, vasopressin and estrogen-stimulated neurophysin: Daily patterns of concentration in cerebrospinal fluid, Science 216: 1416–1418.

    PubMed  CAS  Google Scholar 

  • Posmurová, M., Alda, M., Plavka, R., Filip, V., and Karen, P., 1983, Single-dose effects of two vasopressin derivatives in healthy volunteers: A psychometric study, in: Neuropeptides and Psychosomatic Processes (E. Endroczi, L. Angelucci, K. Scapagnini, and D. De Wied, eds), pp. 73–80, Academiai Kiado, Budapest.

    Google Scholar 

  • Reichert, W. H., and Blass, J. P., 1982, A placebo-controlled trial shows no effect of vasopressin on recovery from closed head injury, Ann. Neurol. 12: 390–392.

    PubMed  CAS  Google Scholar 

  • Reppert, S. M., Artman, H. G., Swaminathan, S., and Fisher, D. A., 1981, Vasopressin exhibits a rhythmic daily pattern in cerebrospinal fluid but not in blood, Science 213: 1256–1257.

    PubMed  CAS  Google Scholar 

  • Reus, V. I., Silberman, E., Post, R. M., Weingartner, H., 1979, d-Amphetamine: Effects on memory in a depressed population, Biol. Psychiatry 13: 345–356.

    Google Scholar 

  • Russell, E. W., 1981, The pathology and clinical examination of memory, in: Handbook of Clinical Neuropsychology (S. B. Filskov and T. J. Boll, eds.), pp. 287–319, Wiley, New York.

    Google Scholar 

  • Schrier, R. W., Berl, T., and Anderson, R. J., 1979, Osmotic and nonosmotic control of vasopressin release, Am. J. Physiol. 236: F321–F329.

    PubMed  CAS  Google Scholar 

  • Segal, M., and Bloom, F. E., 1976, The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity, Brain. Res. 107: 513–525.

    PubMed  CAS  Google Scholar 

  • Squire, L. R., and Davis, H. P., 1981, The pharmacology of memory: A neurobiological perspective, Annu. Rev. Pharmacol. Toxicol. 21: 323–356.

    PubMed  CAS  Google Scholar 

  • Strupp, B., Weingartner, H., Goodwin, F. K., and Gold, P. W., 1983, Neurohypophyseal hormones and cognition, Pharmacol. Ther. 23: 267–279.

    PubMed  CAS  Google Scholar 

  • Sulkava, R., and Amberla, K., 1981, Alzheimer’s disease and senile dementia of Alzheimer type: A neuropsychological study, Acta Neurol. Scand. 65: 541–552.

    Google Scholar 

  • Sundquist, J., Forsling, M. L., Olsson, J. E., and Äkerlund, M., 1983, Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases, J. Neurol. Neurosurg. Psychiatry 46: 14–17.

    PubMed  CAS  Google Scholar 

  • Tanaka, M., De Kloet, E. R., De Wied, D., and Versteeg, D.H.G., 1977, Arginine-8-vasopressin affects catecholamine metabolism in specific brain nuclei, Life Sci. 20: 1799–1808.

    PubMed  CAS  Google Scholar 

  • Timsit-Berthier, M., Mantanus, H., Jacques, M. C., and Legros, J. J., 1980, Utilité de la lysine-vasopressine dans le traitement de l’amnesie post-traumatique, Acta Psychiatrica Belg. 80: 728–747.

    CAS  Google Scholar 

  • Timsit-Berthier, M., Mantanus, H., Devos, J. E., and Spiegel, R., 1982, Action of lysine-vasopressin on human electroencephalographic activity, Neuropsychobiology 8: 248–258.

    PubMed  CAS  Google Scholar 

  • Tinklenberg, J. R., Pfefferbaum, A., and Berger, P. A., 1981a, 1-Desamino-D-arginine-vasopressin in cognitively impaired patients, Psychopharmacol. Bull. 17: 206–207.

    Google Scholar 

  • Tinklenberg, J. R., Pigache, R., Pfefferbaum, A., and Berger, P. A., 1982, Vasopressin peptides and dementia, in: Alzheimer’s Disease. A report of Progress in Research (S. Corkin, K. I. Davis, J. H. Growdon, E. Usdin, and R. J., Wurtman, eds.), pp. 463–469, Raven, New York.

    Google Scholar 

  • Urban, I., and De Wied, D., 1978, Neuropeptides: Effects on paradoxical sleep and theta rhythm in rats, Pharmacol. Biochem. Behav. 8: 51–59.

    PubMed  CAS  Google Scholar 

  • Van Beek-Verbeek, G., Fraenkel, H.M., and Van Ree, J.M., 1983, Des-gly9-[Arg8]-Vasopressin may facilitate methadone detoxification of heroin addicts, Subst. Alcohol Actions/Misues 4: 375–382.

    Google Scholar 

  • Van Wimersma Greidanus, Tj. B., Dogterom, J., and De Wied, D., 1975, Intraventricular administration of anti-vasopressin serum inhibits memory consolidation in rats, Life Sci. 16: 637–644.

    Google Scholar 

  • Van Wimersma Greidanus, Tj. B., Bohus, B., and De Wied, D., 1976, CNS sites of action of ACTH, MSH and vasopressin in relation to avoidance behavior, in Anatomical Neuroendocrinology (W. E. Strumpf and L. D. Grant, eds.), pp. 284–289, Karger. Basel.

    Google Scholar 

  • Versteeg, D. H. G., De Kloet, E. R., Van Wimersma Greidanus, Tj. B., and De Wied, D., 1979, Vasopressin modulates the activity of catecholamine containing neurones in specific brain regions, Neurosci. Lett. 11: 69–73.

    PubMed  CAS  Google Scholar 

  • Vink, M., and Jolies, J., 1985, A new version of the Trail Making task as an information processing task, J. Clin. Exp. Neuropsychol. 7: 162.

    Google Scholar 

  • Vranckx, C. H., Minne, Ph., Benghezal, A., Moeglen, J. M., and Audibert, A., 1979, Vasopressin and schizophrenia, in: Biological Psychiatry Today (J. Obiols, C. Ballus, E. Gonzales, E. Mondus, and J. Pujol, eds.), pp. 753–758, Elsevier/North-Holland, Amsterdam.

    Google Scholar 

  • Waggoner, R. W., Jr., Slonim, A. E., and Armstrong, S. H., 1978, Improved psychological status of children under DDAVP therapy for central diabetes insipidus, Am. J. Psychiatry 135: 361–362.

    PubMed  Google Scholar 

  • Weingartner, H., Rapoport, J. L., Buchsbaum, M. S., Bunney, W. E., Jr., Ebert, M. H., Mikkolsen, E. J., and Caine, E. D., 1980, Cognitive processes in normal and hyperactive children and their response to amphetamine treatment, J. Abnorm. Psychiol. 89: 25–37.

    CAS  Google Scholar 

  • Weingartner, H., Gold, P., Ballenger, J. C., Smallberg, S. A., Summers, R., Rubinow, D. R., Post, R. M., and Goodwin, F. K., 1981a, Effects of vasopressin on human memory functions, Science 211: 601–603.

    PubMed  CAS  Google Scholar 

  • Weingartner, H., Kaye, W., Gold, P., Smallberg, S., Peterson, R., Gillin, J.C., and Ebert, M., 1981b, Vasopressin treatment of cognitive dysfunction in progressive dementia, Life Sci. 29: 2721–2726.

    PubMed  CAS  Google Scholar 

  • Woodward, D. J., Moises, H. C., Waterhouse, B. D., Hoffer, B. J., and Freedman, R., 1979, Modulatory actions of norepinephrine in the central nervous system, Fed. Proc. 38: 2109–2116.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropsychology and Psychobiology, Clinical Psychiatry, State University of Maastricht, 6200 MD, Maastricht, The Netherlands

    Jellemer Jolles

Authors
  1. Jellemer Jolles
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Rochester Medical Center, Rochester, New York, USA

    Don Marshall Gash

  2. Netherlands Institute for Brain Research, Amsterdam, The Netherlands

    Gerard J. Boer

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

Jolles, J. (1987). Vasopressin and Human Behavior. In: Gash, D.M., Boer, G.J. (eds) Vasopressin. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8129-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-8129-1_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-8131-4

  • Online ISBN: 978-1-4615-8129-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation